PharmaCyte Biotech, Inc (PMCB) insider trading
Every open-market stock purchase and sale by PharmaCyte Biotech, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders bought $129K over the last 12 months (2 buys).
- Last insider buy: Joshua Silverman (CEO), $33.3K, 9 months ago.
Last 12 months: insiders bought $129K (2 buys) and sold $0 (0 sales). Last close $0.70 on Jun 7, 2026.
Recent PMCB insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Mar 31, 2026 | Michael M Abecassis (Director) | Bought (not open market) | — |
| Mar 31, 2026 | Wayne Remell Walker (Director) | Bought (not open market) | — |
| Mar 31, 2026 | Robert Weinstein (Director) | Bought (not open market) | — |
| Mar 31, 2026 | Jonathan Schechter (Director) | Bought (not open market) | — |
| Jan 7, 2026 | Joshua Silverman (CEO) | Bought | $33.3K |
| Jan 7, 2026 | Jonathan Schechter (Director) | Bought | $16.9K |
| Jan 6, 2026 | Joshua Silverman (CEO) | Bought | $23.7K |
| Jan 6, 2026 | Jonathan Schechter (Director) | Bought | $15.8K |
| Jan 5, 2026 | Joshua Silverman (CEO) | Bought | $23.5K |
| Jan 5, 2026 | Jonathan Schechter (Director) | Bought | $15.6K |
| Dec 12, 2025 | Joshua Silverman (CEO) | Sold (not open market) | $264K |
| Dec 12, 2025 | Jonathan Schechter (Director) | Sold (not open market) | $68.8K |
| Dec 12, 2025 | Robert Weinstein (Director) | Sold (not open market) | $34.4K |
| Dec 12, 2025 | Michael M Abecassis (Director) | Sold (not open market) | $17.2K |
| Dec 12, 2025 | Wayne Remell Walker (Director) | Sold (not open market) | $17.2K |
| Dec 12, 2025 | Michael M Abecassis (Director) | Bought (not open market) | — |
| Dec 12, 2025 | Joshua Silverman (CEO) | Bought (not open market) | — |
| Dec 12, 2025 | Jonathan Schechter (Director) | Bought (not open market) | — |
| Dec 12, 2025 | Robert Weinstein (Director) | Bought (not open market) | — |
| Dec 12, 2025 | Wayne Remell Walker (Director) | Bought (not open market) | — |
Who's trading PMCB
- Michael M Abecassis, Director: other filings, last Mar 31, 2026
- Jonathan Schechter, Director: bought $48.2K (3 buys), last Mar 31, 2026
- Wayne Remell Walker, Director: other filings, last Mar 31, 2026
- Robert Weinstein, Director: other filings, last Mar 31, 2026
- Joshua Silverman, CEO: bought $80.5K (3 buys), last Jan 7, 2026
Get free alerts when an insider at PharmaCyte Biotech, Inc files a new trade →